KINGDON CAPITAL MANAGEMENT, L.L.C. - Q1 2021 holdings

$979 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 62 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 82.1% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$158,532,000400,000
+100.0%
16.19%
IWM SellISHARES TRput$68,933,000
-26.8%
312,000
-35.0%
7.04%
-30.8%
QQQ SellINVESCO QQQ TRput$64,145,000
-30.3%
201,000
-31.5%
6.55%
-34.2%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$58,799,000
-44.2%
860,261
-30.1%
6.01%
-47.3%
FB BuyFACEBOOK INCcl a$39,270,000
+136.1%
133,331
+119.0%
4.01%
+123.0%
APG SellAPI GROUP CORP$31,610,000
+10.0%
1,528,544
-3.5%
3.23%
+3.9%
GOOGL SellALPHABET INCcap stk cl a$26,699,000
-7.4%
12,945
-21.3%
2.73%
-12.6%
IGV NewISHARES TRput$25,607,00075,000
+100.0%
2.62%
CCK SellCROWN HLDGS INC$22,951,000
-27.4%
236,512
-25.1%
2.34%
-31.5%
VRT SellVERTIV HOLDINGS CO$22,713,000
-26.8%
1,135,672
-31.7%
2.32%
-30.9%
AUPH BuyAURINIA PHARMACEUTICALS INC$22,700,000
-1.6%
1,748,208
+4.8%
2.32%
-7.1%
LAD SellLITHIA MTRS INCcl a$19,020,000
-22.0%
48,758
-41.4%
1.94%
-26.3%
ADS NewALLIANCE DATA SYSTEMS CORP$18,697,000166,800
+100.0%
1.91%
DIS SellDISNEY WALT CO$18,618,000
-7.3%
100,900
-9.0%
1.90%
-12.5%
MSFT NewMICROSOFT CORP$17,423,00073,900
+100.0%
1.78%
CARA BuyCARA THERAPEUTICS INC$15,774,000
+66.4%
726,583
+16.0%
1.61%
+57.2%
DHR NewDANAHER CORPORATION$15,283,00067,900
+100.0%
1.56%
ON NewON SEMICONDUCTOR CORP$15,113,000363,200
+100.0%
1.54%
C NewCITIGROUP INC$14,550,000200,000
+100.0%
1.49%
ARMK NewARAMARK$14,058,000372,100
+100.0%
1.44%
CP NewCANADIAN PAC RY LTD$13,370,00035,250
+100.0%
1.37%
FOUR BuySHIFT4 PMTS INCcl a$13,025,000
+146.8%
158,821
+126.9%
1.33%
+133.1%
CCMP NewCMC MATERIALS INC$12,798,00072,390
+100.0%
1.31%
MTEM BuyMOLECULAR TEMPLATES INC$12,134,000
+69.7%
961,495
+26.3%
1.24%
+60.4%
APO NewAPOLLO GLOBAL MGMT INC$11,753,000250,000
+100.0%
1.20%
BAC NewBK OF AMERICA CORP$11,607,000300,000
+100.0%
1.19%
FIS NewFIDELITY NATL INFORMATION SV$11,516,00081,900
+100.0%
1.18%
SE NewSEA LTDcall$11,162,00050,000
+100.0%
1.14%
BIDU SellBAIDU INCspon adr rep a$11,164,000
-51.2%
51,315
-51.5%
1.14%
-53.9%
FLEX SellFLEX LTDord$11,154,000
-21.3%
609,191
-22.7%
1.14%
-25.7%
SLGL  SOL GEL TECHNOLOGIES$10,310,000
+26.5%
832,8000.0%1.05%
+19.4%
WDAY SellWORKDAY INCcl a$10,258,000
-9.9%
41,292
-13.1%
1.05%
-14.9%
SYF NewSYNCHRONY FINANCIAL$10,165,000250,000
+100.0%
1.04%
TWLO BuyTWILIO INCcl a$10,035,000
+15.1%
29,450
+14.4%
1.02%
+8.7%
TWLO BuyTWILIO INCput$10,018,000
+33.9%
29,400
+33.0%
1.02%
+26.5%
FLXN  FLEXION THERAPEUTICS INC$9,564,000
-22.4%
1,068,5800.0%0.98%
-26.8%
AMZN NewAMAZON COM INC$7,992,0002,583
+100.0%
0.82%
WNS BuyWNS HLDGS LTDspon adr$7,534,000
+11.4%
104,010
+10.8%
0.77%
+5.3%
GTYH  GTY TECHNOLOGY HOLDINGS INC$7,410,000
+23.4%
1,159,6000.0%0.76%
+16.5%
CTSH NewCOGNIZANT TECHNOLOGY SOLUTIOcl a$6,968,00089,200
+100.0%
0.71%
SNV NewSYNOVUS FINL CORP$6,863,000150,000
+100.0%
0.70%
ATNX SellATHENEX INC$6,656,000
-84.8%
1,547,879
-60.9%
0.68%
-85.6%
SE SellSEA LTDsponsord ads$5,893,000
-49.1%
26,400
-54.6%
0.60%
-51.9%
BIDU NewBAIDU INCcall$5,439,00025,000
+100.0%
0.56%
GNCA  GENOCEA BIOSCIENCES INC$5,344,000
+12.0%
1,972,0560.0%0.55%
+5.8%
RAPT SellRAPT THERAPEUTICS INC$4,973,000
-0.7%
224,021
-11.7%
0.51%
-6.3%
TENB SellTENABLE HLDGS INC$4,766,000
-50.7%
131,700
-28.8%
0.49%
-53.4%
SCYX  SCYNEXIS INC$4,661,000
+3.8%
587,0480.0%0.48%
-2.1%
XAIR BuyBEYOND AIR INC$3,824,000
+42.0%
695,228
+36.0%
0.39%
+34.4%
PCT NewPURECYCLE TECHNOLOGIES INC$3,705,000145,300
+100.0%
0.38%
TMQ  TRILOGY METALS INC NEW$3,581,000
+7.0%
1,673,4610.0%0.37%
+1.1%
SESN SellSESEN BIO INC$3,410,000
+47.6%
1,311,672
-23.4%
0.35%
+39.2%
RAPT NewRAPT THERAPEUTICS INCcall$3,330,000150,000
+100.0%
0.34%
GEG  GREAT ELM GROUP INC$3,072,000
-15.3%
1,259,0490.0%0.31%
-19.9%
PDAC NewPERIDOT ACQUISITION CORP$2,982,000280,000
+100.0%
0.30%
MSACU NewMEDICUS SCIENCES ACQUISITIONunit 99/99/9999$2,955,000300,000
+100.0%
0.30%
EUCRU  EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027$2,012,000
-5.6%
200,0000.0%0.21%
-10.8%
IFRX NewINFLARX NV$1,560,000400,000
+100.0%
0.16%
ACET NewADICET BIO INC$1,308,000100,000
+100.0%
0.13%
XCUR  EXICURE INC$740,000
+23.1%
339,3950.0%0.08%
+16.9%
RXDX NewPROMETHEUS BIOSCIENCES INC$730,00040,000
+100.0%
0.08%
CRC  CALIFORNIA RES CORP$703,000
+2.0%
29,1990.0%0.07%
-4.0%
XLRN ExitACCELERON PHARMA INC$0-15,000
-100.0%
-0.21%
PD ExitPAGERDUTY INCcall$0-52,300
-100.0%
-0.24%
AUPH ExitAURINIA PHARMACEUTICALS INCcall$0-200,000
-100.0%
-0.30%
WORK ExitSLACK TECHNOLOGIES INC$0-75,000
-100.0%
-0.34%
TENB ExitTENABLE HLDGS INCput$0-73,200
-100.0%
-0.41%
GOOS ExitCANADA GOOSE HLDGS INC$0-181,700
-100.0%
-0.58%
DIS ExitDISNEY WALT COput$0-30,600
-100.0%
-0.60%
STPK ExitSTAR PEAK ENERGY TRANSITIONcl a$0-286,000
-100.0%
-0.63%
WDAY ExitWORKDAY INCput$0-25,000
-100.0%
-0.65%
BFT ExitFOLEY TRASIMENE ACQUISITION$0-575,450
-100.0%
-0.94%
MIME ExitMIMECAST LTD$0-173,924
-100.0%
-1.07%
SRI ExitSTONERIDGE INC$0-348,301
-100.0%
-1.14%
SUMO ExitSUMO LOGIC INCput$0-400,000
-100.0%
-1.24%
RADI ExitRADIUS GLOBAL INFRASTRCTRE I$0-1,000,000
-100.0%
-1.39%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO Lcall$0-150,000
-100.0%
-1.39%
IOVA ExitIOVANCE BIOTHERAPEUTICS INCput$0-300,000
-100.0%
-1.51%
JD ExitJD.COM INCspon adr cl a$0-174,500
-100.0%
-1.66%
PRPL ExitPURPLE INNOVATION INC$0-593,000
-100.0%
-2.11%
CPRT ExitCOPART INC$0-157,590
-100.0%
-2.17%
XBI ExitSPDR SER TRput$0-300,000
-100.0%
-4.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-13

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (978940000.0 != 978939000.0)

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings